Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Microbot Medical (MBOT) has issued an update.
Microbot Medical Inc. has successfully completed the inaugural patient procedure with its LIBERTY® Endovascular Robotic Surgical System at Brigham and Women’s Hospital, marking a significant step in their clinical trial for the innovative device. This milestone is expected to bolster their efforts for FDA submission and future market release. The company’s forward-looking statements indicate a positive outlook on achieving regulatory goals but also acknowledge potential variations in future results.
Find detailed analytics on MBOT stock on TipRanks’ Stock Analysis page.
